Literature DB >> 30658994

Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes.

Carlo Maurer1,2,3, Sam R Holmstrom1,2,3, Jing He1,4,5, Pasquale Laise1,4,5, Tao Su1,3, Aqeel Ahmed1,3, Hanina Hibshoosh1,5, John A Chabot1,6, Paul E Oberstein7, Antonia R Sepulveda1,5, Jeanine M Genkinger1,8, Jiapeng Zhang9, Alina C Iuga1,5, Mukesh Bansal10, Andrea Califano1,4,5, Kenneth P Olive1,2,3.   

Abstract

OBJECTIVE: Pancreatic ductal adenocarcinoma (PDA) has among the highest stromal fractions of any cancer and this has complicated attempts at expression-based molecular classification. The goal of this work is to profile purified samples of human PDA epithelium and stroma and examine their respective contributions to gene expression in bulk PDA samples.
DESIGN: We used laser capture microdissection (LCM) and RNA sequencing to profile the expression of 60 matched pairs of human PDA malignant epithelium and stroma samples. We then used these data to train a computational model that allowed us to infer tissue composition and generate virtual compartment-specific expression profiles from bulk gene expression cohorts.
RESULTS: Our analysis found significant variation in the tissue composition of pancreatic tumours from different public cohorts. Computational removal of stromal gene expression resulted in the reclassification of some tumours, reconciling functional differences between different cohorts. Furthermore, we established a novel classification signature from a total of 110 purified human PDA stroma samples, finding two groups that differ in the extracellular matrix-associated and immune-associated processes. Lastly, a systematic evaluation of cross-compartment subtypes spanning four patient cohorts indicated partial dependence between epithelial and stromal molecular subtypes.
CONCLUSION: Our findings add clarity to the nature and number of molecular subtypes in PDA, expand our understanding of global transcriptional programmes in the stroma and harmonise the results of molecular subtyping efforts across independent cohorts. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  pancreatic cancer

Mesh:

Year:  2019        PMID: 30658994      PMCID: PMC6509007          DOI: 10.1136/gutjnl-2018-317706

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

Review 1.  Stromal biology and therapy in pancreatic cancer: a changing paradigm.

Authors:  Albrecht Neesse; Hana Algül; David A Tuveson; Thomas M Gress
Journal:  Gut       Date:  2015-05-20       Impact factor: 23.059

2.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.

Authors:  Andrew D Rhim; Paul E Oberstein; Dafydd H Thomas; Emily T Mirek; Carmine F Palermo; Stephen A Sastra; Erin N Dekleva; Tyler Saunders; Claudia P Becerra; Ian W Tattersall; C Benedikt Westphalen; Jan Kitajewski; Maite G Fernandez-Barrena; Martin E Fernandez-Zapico; Christine Iacobuzio-Donahue; Kenneth P Olive; Ben Z Stanger
Journal:  Cancer Cell       Date:  2014-05-22       Impact factor: 31.743

3.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

Authors:  Paolo P Provenzano; Carlos Cuevas; Amy E Chang; Vikas K Goel; Daniel D Von Hoff; Sunil R Hingorani
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

4.  Whole genomes redefine the mutational landscape of pancreatic cancer.

Authors:  Nicola Waddell; Marina Pajic; Ann-Marie Patch; David K Chang; Karin S Kassahn; Peter Bailey; Amber L Johns; David Miller; Katia Nones; Kelly Quek; Michael C J Quinn; Alan J Robertson; Muhammad Z H Fadlullah; Tim J C Bruxner; Angelika N Christ; Ivon Harliwong; Senel Idrisoglu; Suzanne Manning; Craig Nourse; Ehsan Nourbakhsh; Shivangi Wani; Peter J Wilson; Emma Markham; Nicole Cloonan; Matthew J Anderson; J Lynn Fink; Oliver Holmes; Stephen H Kazakoff; Conrad Leonard; Felicity Newell; Barsha Poudel; Sarah Song; Darrin Taylor; Nick Waddell; Scott Wood; Qinying Xu; Jianmin Wu; Mark Pinese; Mark J Cowley; Hong C Lee; Marc D Jones; Adnan M Nagrial; Jeremy Humphris; Lorraine A Chantrill; Venessa Chin; Angela M Steinmann; Amanda Mawson; Emily S Humphrey; Emily K Colvin; Angela Chou; Christopher J Scarlett; Andreia V Pinho; Marc Giry-Laterriere; Ilse Rooman; Jaswinder S Samra; James G Kench; Jessica A Pettitt; Neil D Merrett; Christopher Toon; Krishna Epari; Nam Q Nguyen; Andrew Barbour; Nikolajs Zeps; Nigel B Jamieson; Janet S Graham; Simone P Niclou; Rolf Bjerkvig; Robert Grützmann; Daniela Aust; Ralph H Hruban; Anirban Maitra; Christine A Iacobuzio-Donahue; Christopher L Wolfgang; Richard A Morgan; Rita T Lawlor; Vincenzo Corbo; Claudio Bassi; Massimo Falconi; Giuseppe Zamboni; Giampaolo Tortora; Margaret A Tempero; Anthony J Gill; James R Eshleman; Christian Pilarsky; Aldo Scarpa; Elizabeth A Musgrove; John V Pearson; Andrew V Biankin; Sean M Grimmond
Journal:  Nature       Date:  2015-02-26       Impact factor: 49.962

5.  The Human Protein Atlas--a tool for pathology.

Authors:  F Pontén; K Jirström; M Uhlen
Journal:  J Pathol       Date:  2008-12       Impact factor: 7.996

Review 6.  Inflammatory networks and immune surveillance of pancreatic carcinoma.

Authors:  Robert H Vonderheide; Lauren J Bayne
Journal:  Curr Opin Immunol       Date:  2013-02-17       Impact factor: 7.486

7.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

Authors:  Andrew V Biankin; Nicola Waddell; Karin S Kassahn; Marie-Claude Gingras; Lakshmi B Muthuswamy; Amber L Johns; David K Miller; Peter J Wilson; Ann-Marie Patch; Jianmin Wu; David K Chang; Mark J Cowley; Brooke B Gardiner; Sarah Song; Ivon Harliwong; Senel Idrisoglu; Craig Nourse; Ehsan Nourbakhsh; Suzanne Manning; Shivangi Wani; Milena Gongora; Marina Pajic; Christopher J Scarlett; Anthony J Gill; Andreia V Pinho; Ilse Rooman; Matthew Anderson; Oliver Holmes; Conrad Leonard; Darrin Taylor; Scott Wood; Qinying Xu; Katia Nones; J Lynn Fink; Angelika Christ; Tim Bruxner; Nicole Cloonan; Gabriel Kolle; Felicity Newell; Mark Pinese; R Scott Mead; Jeremy L Humphris; Warren Kaplan; Marc D Jones; Emily K Colvin; Adnan M Nagrial; Emily S Humphrey; Angela Chou; Venessa T Chin; Lorraine A Chantrill; Amanda Mawson; Jaswinder S Samra; James G Kench; Jessica A Lovell; Roger J Daly; Neil D Merrett; Christopher Toon; Krishna Epari; Nam Q Nguyen; Andrew Barbour; Nikolajs Zeps; Nipun Kakkar; Fengmei Zhao; Yuan Qing Wu; Min Wang; Donna M Muzny; William E Fisher; F Charles Brunicardi; Sally E Hodges; Jeffrey G Reid; Jennifer Drummond; Kyle Chang; Yi Han; Lora R Lewis; Huyen Dinh; Christian J Buhay; Timothy Beck; Lee Timms; Michelle Sam; Kimberly Begley; Andrew Brown; Deepa Pai; Ami Panchal; Nicholas Buchner; Richard De Borja; Robert E Denroche; Christina K Yung; Stefano Serra; Nicole Onetto; Debabrata Mukhopadhyay; Ming-Sound Tsao; Patricia A Shaw; Gloria M Petersen; Steven Gallinger; Ralph H Hruban; Anirban Maitra; Christine A Iacobuzio-Donahue; Richard D Schulick; Christopher L Wolfgang; Richard A Morgan; Rita T Lawlor; Paola Capelli; Vincenzo Corbo; Maria Scardoni; Giampaolo Tortora; Margaret A Tempero; Karen M Mann; Nancy A Jenkins; Pedro A Perez-Mancera; David J Adams; David A Largaespada; Lodewyk F A Wessels; Alistair G Rust; Lincoln D Stein; David A Tuveson; Neal G Copeland; Elizabeth A Musgrove; Aldo Scarpa; James R Eshleman; Thomas J Hudson; Robert L Sutherland; David A Wheeler; John V Pearson; John D McPherson; Richard A Gibbs; Sean M Grimmond
Journal:  Nature       Date:  2012-10-24       Impact factor: 49.962

8.  Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.

Authors:  Siân Jones; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; Hirohiko Kamiyama; Antonio Jimeno; Seung-Mo Hong; Baojin Fu; Ming-Tseh Lin; Eric S Calhoun; Mihoko Kamiyama; Kimberly Walter; Tatiana Nikolskaya; Yuri Nikolsky; James Hartigan; Douglas R Smith; Manuel Hidalgo; Steven D Leach; Alison P Klein; Elizabeth M Jaffee; Michael Goggins; Anirban Maitra; Christine Iacobuzio-Donahue; James R Eshleman; Scott E Kern; Ralph H Hruban; Rachel Karchin; Nickolas Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

9.  Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.

Authors:  Kenneth P Olive; Michael A Jacobetz; Christian J Davidson; Aarthi Gopinathan; Dominick McIntyre; Davina Honess; Basetti Madhu; Mae A Goldgraben; Meredith E Caldwell; David Allard; Kristopher K Frese; Gina Denicola; Christine Feig; Chelsea Combs; Stephen P Winter; Heather Ireland-Zecchini; Stefanie Reichelt; William J Howat; Alex Chang; Mousumi Dhara; Lifu Wang; Felix Rückert; Robert Grützmann; Christian Pilarsky; Kamel Izeradjene; Sunil R Hingorani; Pearl Huang; Susan E Davies; William Plunkett; Merrill Egorin; Ralph H Hruban; Nigel Whitebread; Karen McGovern; Julian Adams; Christine Iacobuzio-Donahue; John Griffiths; David A Tuveson
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

10.  Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.

Authors:  Rémy Nicolle; Yuna Blum; Laetitia Marisa; Celine Loncle; Odile Gayet; Vincent Moutardier; Olivier Turrini; Marc Giovannini; Benjamin Bian; Martin Bigonnet; Marion Rubis; Nabila Elarouci; Lucile Armenoult; Mira Ayadi; Pauline Duconseil; Mohamed Gasmi; Mehdi Ouaissi; Aurélie Maignan; Gwen Lomberk; Jean-Marie Boher; Jacques Ewald; Erwan Bories; Jonathan Garnier; Anthony Goncalves; Flora Poizat; Jean-Luc Raoul; Veronique Secq; Stephane Garcia; Philippe Grandval; Marine Barraud-Blanc; Emmanuelle Norguet; Marine Gilabert; Jean-Robert Delpero; Julie Roques; Ezequiel Calvo; Fabienne Guillaumond; Sophie Vasseur; Raul Urrutia; Aurélien de Reyniès; Nelson Dusetti; Juan Iovanna
Journal:  Cell Rep       Date:  2017-11-28       Impact factor: 9.423

View more
  54 in total

1.  Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets.

Authors:  Tessa Ys Le Large; Giulia Mantini; Laura L Meijer; Thang V Pham; Niccola Funel; Nicole Ct van Grieken; Bart Kok; Jaco Knol; Hanneke Wm van Laarhoven; Sander R Piersma; Connie R Jimenez; G Kazemier; Elisa Giovannetti; Maarten F Bijlsma
Journal:  JCI Insight       Date:  2020-08-06

2.  Precision Medicine in Pancreatic Disease-Knowledge Gaps and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Mark E Lowe; Dana K Andersen; Richard M Caprioli; Jyoti Choudhary; Zobeida Cruz-Monserrate; Anil K Dasyam; Christopher E Forsmark; Fred S Gorelick; Joe W Gray; Mark Haupt; Kimberly A Kelly; Kenneth P Olive; Sylvia K Plevritis; Noa Rappaport; Holger R Roth; Hanno Steen; S Joshua Swamidass; Temel Tirkes; Aliye Uc; Kirill Veselkov; David C Whitcomb; Aida Habtezion
Journal:  Pancreas       Date:  2019 Nov/Dec       Impact factor: 3.327

3.  The vascular landscape of human cancer.

Authors:  Benjamin M Kahn; Alfredo Lucas; Rohan G Alur; Maximillian D Wengyn; Gregory W Schwartz; Jinyang Li; Kathryn Sun; H Carlo Maurer; Kenneth P Olive; Robert B Faryabi; Ben Z Stanger
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 4.  GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets.

Authors:  Krishna Sriram; Cristina Salmerón; Shu Z Wiley; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

5.  Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer.

Authors:  Naim U Rashid; Xianlu L Peng; Chong Jin; Richard A Moffitt; Keith E Volmar; Brian A Belt; Roheena Z Panni; Timothy M Nywening; Silvia G Herrera; Kristin J Moore; Sarah G Hennessey; Ashley B Morrison; Ryan Kawalerski; Apoorve Nayyar; Audrey E Chang; Benjamin Schmidt; Hong Jin Kim; David C Linehan; Jen Jen Yeh
Journal:  Clin Cancer Res       Date:  2019-11-21       Impact factor: 12.531

Review 6.  Evolving Treatment Paradigms for Pancreatic Cancer.

Authors:  Rami Abbassi; Roland M Schmid
Journal:  Visc Med       Date:  2019-11-07

7.  Cell of Origin Influences Pancreatic Cancer Subtype.

Authors:  Brittany M Flowers; Hang Xu; Abigail S Mulligan; Kathryn J Hanson; Jose A Seoane; Hannes Vogel; Christina Curtis; Laura D Wood; Laura D Attardi
Journal:  Cancer Discov       Date:  2021-03       Impact factor: 39.397

8.  Cross-tissue organization of the fibroblast lineage.

Authors:  Matthew B Buechler; Rachana N Pradhan; Akshay T Krishnamurty; Christian Cox; Aslihan Karabacak Calviello; Amber W Wang; Yeqing Angela Yang; Lucinda Tam; Roger Caothien; Merone Roose-Girma; Zora Modrusan; Joseph R Arron; Richard Bourgon; Sören Müller; Shannon J Turley
Journal:  Nature       Date:  2021-05-12       Impact factor: 49.962

9.  Gene Targeting in Disease Networks.

Authors:  Deborah Weighill; Marouen Ben Guebila; Kimberly Glass; John Platig; Jen Jen Yeh; John Quackenbush
Journal:  Front Genet       Date:  2021-04-23       Impact factor: 4.772

10.  MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer.

Authors:  Hans Martin Singh; Mathias Felix Leber; Sascha Bossow; Christine E Engeland; Jan Dessila; Christian Grossardt; Karim Zaoui; John C Bell; Dirk Jäger; Christof von Kalle; Guy Ungerechts
Journal:  Mol Ther Oncolytics       Date:  2021-05-05       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.